Cytokine-induced venodilatation in humans in vivo: eNOS masquerading as iNOS

Cardiovascular Research

Volumn 41, Issue 3, 1999, Pages 754-764

  Bhagat, Kiran ^a   Hingorani, Aroon D ^a   Palacios, Miriam ^a   Charles, Ian G ^a   Vallance, Patrick ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cytokines; GTP cyclohydrolase 1; Human; Inducible nitric oxide synthase; Nitric oxide; Septic shock; Tetrahydrobiopterin; Veins

Indexed keywords

AMINOGUANIDINE; CYTOKINE; ENZYME INHIBITOR; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NORADRENALIN; TETRAHYDROBIOPTERIN; TUMOR NECROSIS FACTOR ALPHA;

ADRENERGIC STIMULATION; ADULT; ARTICLE; DOSE RESPONSE; ENDOTOXEMIA; ENZYME INDUCTION; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; SEPTIC SHOCK; VEIN DILATATION; VEIN TONE; VENOCONSTRICTION;

ADULT; ARGININE; BIOPTERIN; BRADYKININ; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FEMALE; GENE EXPRESSION; GUANIDINES; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; NOREPINEPHRINE; OMEGA-N-METHYLARGININE; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SHOCK, SEPTIC; TUMOR NECROSIS FACTOR-ALPHA; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 0033062214     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(98)00249-1     Document Type: Article

References (35)

1. Snell R.J., Parrillo J.E. Cardiovascular dysfunction in septic shock. Chest. 99:1991;1000-1009.
2. Parrillo J.E. Pathogenetic mechanisms of septic shock. N Engl J Med. 328:1993;1471-1477.
3. Bradley S., Chasis H., Goldring W., Smith H. Haemodynamic alterations in normotensive and hypertensive subjects during the pyrogenic reaction. J Clin Invest. 24:1945;749-758.
4. Petros A., Bennett D., Vallance P. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet. 338:1991;1557-1558.
5. Thorin-Trescases N., Hamilton C.A., Reid J.L.et al. Inducible L-arginine/nitric oxide pathway in human internal mammary artery and saphenous vein. Am J Physiol. 268:1995;H1122-H1132.
6. Bhagat K., Collier J., Vallance P. Local venous responses to endotoxin in humans. Circulation. 94:1996;490-497.
7. Bhagat K., Vallance P. Inflammatory cytokines impair endothelium-dependent dilatation in humans, in vivo. Circulation. 96:1997;3042-3047.
8. Helsinki. World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. Cardiovasc Res 1997;35:2-3.
9. Haynes W.G., Hand M.F., Johnstone H.A., Padfield P.L., Webb D.J. Direct and sympathetically mediated venoconstriction in essential hypertension. Enhanced responses to endothelin-1. J Clin Invest. 94:1994;1359-1364.
10. Benjamin N., Collier J.G., Webb D.J. Angiotensin II augments sympathetically induced venoconstriction in man. Clin Sci. 75:1988;337-340.
11. Duggan J., Love V., Lyons R. A study of reflex venomotor reactions in man. Circulation. 7:1953;869-873.
12. Samueloff S.L., Bevegard B.S., Shepherd J.T. Temporary arrest of circulation to a limb for the study of venomotor reactions in man. J Appl Physiol. 21:1966;341-346.
13. Rees D.D., Palmer R.M., Hodson H.F., Moncada S. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol. 96:1989;418-424.
14. Misko T.P., Moore W.M., Kasten T.P.et al. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol. 233:1993;119-125.
15. Vallance P., Collier J., Moncada S. Nitric oxide synthesised from L-arginine mediates endothelium dependent dilatation in human veins in vivo. Cardiovasc Res. 23:1989;1053-1057.
16. Lewis T., Landis E. Some physiological effects of sympathetic ganglionectomy in the human being and its effects in the case of Raynaud's malady. Heart. 15:1935;151-176.
17. Klosterhalfen B., Horstmann-Jungemann K., Vogel P.et al. Time course of various inflammatory mediators during recurrent endotoxemia. Biochem Pharmacol. 43:1992;2103-2109.
18. Schneemann M., Schoedon G., Hofer S.et al. Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J Infect Dis. 167:1993;1358-1363.
19. Yan L., Vandivier R.W., Suffredini A.F., Danner R.L. Human polymorphonuclear leukocytes lack detectable nitric oxide synthase activity. J Immunol. 153:1994;1825-1834.
20. Stamler J.S., Loh E., Roddy M.A., Currie K.E., Creager M.A. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation. 89:1994;2035-2040.
21. Schoedon G., Schneemann M., Hofer S., Guerrero L.et al. Regulation of the L-arginine-dependent and tetrahydrobiopterin-dependent biosynthesis of nitric oxide in murine macrophages. Eur J Biochem. 213:1993;833-839.
22. Ichinose H., Ohye T., Matsuda Y.et al. Characterization of mouse and human GTP cyclohydrolase I genes. Mutations in patients with GTP cyclohydrolase I deficiency. J Biol Chem. 270:1995;10062-10071.
23. Rosenkranz Weiss P., Sessa W.C., Milstien W.C.et al. Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. Elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity. J Clin Invest. 93:1994;2236-2243.
24. Werner Felmayer G., Werner E.R., Fuchs D.et al. Pteridine biosynthesis in human endothelial cells. Impact on nitric oxide-mediated formation of cyclic GMP. J Biol Chem. 268:1993;1842-1846.
25. Katusic Z.S., Stelter A., Milstien S. Cytokines stimulate GTP cyclohydrolase I gene expression in cultured human umbilical vein endothelial cells. Arterioscl Thromb Vasc Biol. 18:1998;27-32.
26. Kukor Z., Meszaros G., Hertelendy F., Toth M. Calcium-dependent nitric oxide synthesis is potently stimulated by tetrahydrobiopterin in human primordial placenta. Placenta. 17:1996;69-73.
27. Gross S.S., Levi R. Tetrahydrobiopterin synthesis. An absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle. J Biol Chem. 267:1992;25722-25729.
28. Yates D.H., Kharitonov S.A., Thomas P.S., Barnes P.J. Endogenous nitric oxide is decreased in asthmatic patients by an inhibitor of inducible nitric oxide synthase. Am J Resp Crit Care Med. 154:1996;247-250.
29. MacAllister R.J., Whitley G.S., Vallance P. Effects of guanidino and uremic compounds on nitric oxide pathways. Kidney Int. 45:1994;737-742.
30. Wolff D.J., Lubeskie A. Aminoguanidine is an isoform-selective, mechanism-based inactivator of nitric oxide synthase. Arch Biochem Biophys. 316:1995;290-301.
31. Werner E.R., Werner Felmayer G., Wachter H. Tetrahydrobiopterin and cytokines. Proc Soc Exp Biol Med. 203:1993;1-12.
32. Wever R.M.F., van Dam T., van Rijn H.J., de Groot F., Rabelink T.J. Tetrahydrobiopterin regulates superoxide and nitric oxide generation by recombinant endothelial nitric oxide synthase. Biochem Biophys Res Commun. 237:1997;340-344.
33. Delogu G., Casula M.A., Mancini P., Tellan G., Signore L. Serum neopterin and soluble interleukin-2 receptor for prediction of a shock state in gram-negative sepsis. J Crit Care. 10:1995;64-71.
34. Waydhas C., Nast Kolb D., Jochum M.et al. Inflammatory mediators, infection, sepsis, and multiple organ failure after severe trauma. Arch Surg. 127:1992;460-467.
35. Strohmaier W., Mauritz W., Gaudernak T.et al. Septic focus localized by determination of arterio-venous difference in neopterin blood levels. Circ Shock. 38:1992;219-221.